remains to be demonstrated, but circulating antibody has been shown to move to higher molecular weight fractions soon after injection (Begent et al. 1980) , This apparently complexed material is then cleared much more rapidly from the circulation. It seems probable that an equilibrium exists between antibody and antigen-antibody complexes, but whether it is antibody or complex that localizes in tumour remains to be determined.
Potential improvements
Isotopes: The relatively poor tumour-specific localization of the antiserum severely limits the usefulness of the technique as a diagnostic tool, and virtually eliminates it as a therapeutic weapon. Subtraction scanning has enabled the demonstration of tumour deposits at low levels of tumour uptake and, in addition, the physical and biological characteristics of 131 I give poor tumour count rates which prevent accurate localization and mapping of small tumour deposits. The statistics of subtraction scanning have received scant attention, and it is encouraging to hear of the modifications described by Goldenberg and his colleagues (1983) using selective organ subtraction. All isotopic and detection systems have their strengths and limitations, and comparisons will not be possible until the statistical limits of positive scans are measured and reported. Alternatively, t23I gave better imaging with high count rates because of its more favourable dosimetry (Epenetos et al. 1982) , and 111 I is giving promising results because of its suitability for detection by conventional gamma cameras and intracellular accumulation (Fairweather et al. 1983a) .
Imaging: Improvement of the scanning technique itself could also make an important contribution to the problem, and many different collimating systems have been used to improve target-to-background ratio. Furthermore, tomographic imaging has been applied to radioisotopic detection as it has to external radiation, with a corresponding improvement in detection rate particularly of smaller tumour deposits (Berche et al. 1982 ).
Positron camera: Yet another modification which is dependent upon physical considerations is the use of paired wire detectors to receive positron annihilation gamma rays (Brownell et al. 1982) . In collaboration with the Rutherford team, and using 124 1, we have succeeded in satisfactorily delineating the thyroid gland (Bateman et at. 1983), but have not applied this technique to RID. The size of the detector is still small and studies of the human trunk are not therefore possible. Although excellent localization of narrow areas such as the neck is readily attainable, tumour detection in the trunk is much more difficult where deposits are at a considerable depth.
Antibody fragments: It might be anticipated that the specific antibody-binding fragment of the immunoglobulin might assist tissue. penetration and also increase renal clearance of unbound labels. Fab fragments have been shown to localize to tumour deposits (Mach et al. 1981) , although improvement in tumour imaging remains to be demonstrated.
Plasma clearance: Improved imaging might also result from blood plasma clearance of nonbound antibody, and this has been demonstrated by the injection of liposomally-entrapped second antibody (Begent et al. 1982) . A reduction of 50% in blood radioactivity was obtained by this technique in 4 out of 5 patients, enhancing imaging of the tumour in 3. The aim of the method is to eliminate the need for subtraction scanning. Whether the liposomes are necessary has been called into question, and it may be that clearance can be obtained simply by the use of injected second antibody ).
Monoclonal antibodies: Probably the greatest current interest centres on the use of monoclonal antibodies, as it is hoped that their specific properties will result in much more precise tumour localization (Mach et al. 1981) . Two studies have reported antibodies directed to germ cell tumours growing in mice (Moshakis et al. 1981b , Levine et al. 1980 , and work is in progress on other tumours both in animals and humans. There is an encouraging reduction in accumulation of radioactive antibody in reticuloendothelial and other tissues of animals, whilst the radioactivity of tumour tissue, already higher than other organs at two days, appears to hold up for several days whilst it is clearing from normal tissues. Tumour-to-blood ratios of 10: I are reported, with higher figures for other tissues.
Monoclonal antibodies are likely to vary widely in their ability to localize in tumours, and a model is necessary to select those which are best. Successful application of this technique has now been described in patients (Berche et al. 1982 , Farrands et al. 1982 ) with a result similar to but not better than those obtained from polyclonal antisera. Further observations are needed to see whether these figures can be improved upon.
Scanning for other tumours With others we have extended the examination of this technique to different tumour types, particularly germ cell and endocrine tumours. The use of alphafetoprotein (AFP) as a marker has been encouraging (Halsall et al. 1981) , with a high detection rate unaffected by high levels of circulating antigen (Table 2) . This work initiated a therapeutic approach, with surgical excision of localized deposits. This is also currently being applied to recurrent colorectal cancer, but the data on local recurrence do not give reason for optimism. Human chorionic gonadotrophin (HCG) is perhaps the best known tumour marker, and it is not surprising that similar satisfactory results have also been obtained using appropriate antisera (Begent et al. 1980 , Goldenberg et al. 1981 .
We have studied patients with thyroid cancer using an anti thyroglobulin raised in sheep (Fairweather et al. 1983b) , and uptake of radioiodide was inhibited by the use of KI and KC0 4 • Studies in II patients revealed 14 definitely abnormal areas in 7, and a further 7 probably abnormal. Good correlation was obtained with other criteria, and comparison indicated that antibody scanning was on the whole the most sensitive staging procedure. Nonetheless, the usually agreed limit of detectable tumour size was confirmed and deposits less than 1.7 em in diameter were not seen. Recently we have extended these studies to the use of an anti-insulin antibody (Fairweather et al. 1982 ) and produced positive scans later shown to correlate with the presence of insulinomas in 4 of 6 patients studied.
Conclusions
The technique of RID has developed an area of patient investigation of considerable interest and potential for aiding the diagnosis and treatment of cancer. At present, there are limited clinical situations where the patient might benefit from its use, but the techniques are under continuous development, and imaging is improving rapidly. If tumour concentrations of radiolabelled antibody can be improved to the extent of those demonstrated in animal models, then widespread application is inevitable. Cancer mapping could be of great value to the surgeon or radiotherapist, and precise staging would greatly aid the design and conduct of chemotherapy trials. Localization of certain benign but hormone-secreting tumours would also be of great clinical benefit, as these lesions are frequently inaccessible to present investigative techniques.
